Medical Products Supplies Companies

Floor 5, Building 4, North Zhongshan No. 1 Road, Hongkou District, 200000 Shanghai
China
Telephone +86-10-65248530
Fax +86-10-65249508
jinjing@reliachina.com
http://www.reliabiotech.com

Product Categories

Product categories

03 Diagnostic Tests
03.02 Immunochemistry testing, immunology testing
03.02.02 Diagnostic rapid tests

Diagnostic rapid tests

TZ-301 immunofluorescence detector
MINI Multifunctional Immunoassay Instrument
TZ-320 immunofluorescence detector

Our products

Product category: Diagnostic rapid tests
TZ-301 immunofluorescence detector

Provides accurate and fast analysis
Temperature control
Two-way connection, compatible with HIS, LIS.
automatic recognition

MINI Multifunctional Immunoassay Instrument

Product category: Diagnostic rapid tests
MINI Multifunctional Immunoassay Instrument
Compact, portable and durable

Hand built portable instrument thats easy to operate.Built in rechargeable, long lasting batteryStable and reliable performance.
TZ-320 immunofluorescence detector

Product category: Diagnostic rapid tests
TZ-320 immunofluorescence detector
Fully automatic

Is fully capable of automatic sample identification, calibration and measurement.Maintains a constant temperature that is optimal for fluorescence.Results are as consistently accurate and reliable as other imported chemiluminescence systems.

ad: contact information

About Us

Company details
Since its foundation in 2001, ReLIA Biotech has been at the forefront of research in point of care testing technologies, with it’s primary research and development centre located in Silicon Valley, California. Currently, it holds its Asian Pacific headquarters at the Shekou Free Trade Zone, Shenzhen, as well as large scale production and R&D centers in Shenzhen and Jiangsu. These centers have passed both the CFDA and ISO-13485 audit certification.

Under the guidance of Dr. Willian J. Rutter, our company’s founder, ReLIA has adhered to a diligent attitude towards research. We mold modern developments into technological advancement/systems, which promote rapid diagnostic services and improve the health and wellbeing of patients whilst simultaneously reducing medical costs.

Currently, the company focuses on two categories of rapid detection systems: The multi-functional immunoassay system and immunofluorescence detection system. Both of these systems cover the detection of biomarkers for cardiovascular, acute kidney injury and inflammatory related conditions.

ad: company